abstract |
The present invention relates to the compound of formula I representative, or its polymorphic form, solvate, ester, tautomer, enantiomer, pharmacy acceptable salt or prodrug:n And a kind of pharmaceutical composition, comprise one or more pharmaceutically acceptable excipient and above-claimed cpds.And above-claimed cpd or pharmaceutical composition suppress the method for HSP90, and treatment suffers from the method for individuality of the illness of HSP90 mediation. |